av/innate-pharma-sa--big.svg

NASDAQ:IPHA

Innate Pharma S.A.

  • Stock

USD

Last Close

2.10

26/07 15:35

Market Cap

163.52M

Beta: 0.32

Volume Today

31.78K

Avg: 17.77K

PE Ratio

−1.87

PFCF: −9.30

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.05M
-
1.22M
16.21%
745K
38.68%
3.16M
-
3.16M
0%
2.80M
11.50%
2.80M
0%
-1K
-
-1K
0%
average payables
4.91M
-
5.99M
22.18%
33.19M
453.82%
37.57M
13.18%
17.78M
52.66%
30.82M
73.31%
34.81M
12.92%
28.74M
17.44%
29.06M
1.11%
24.74M
14.85%
18.96M
23.35%
average receivables
7.15M
-
7.82M
9.49%
9.27M
18.44%
17.75M
91.56%
20.32M
14.47%
80.86M
297.96%
79.89M
1.20%
17.42M
78.20%
20.06M
15.15%
28.38M
41.51%
46.95M
65.42%
book value per share
1.04
-
1.49
42.95%
1.35
9.30%
1.60
18.53%
1.58
1.13%
2.85
79.92%
3.25
14.20%
1.98
39.19%
1.35
31.64%
0.68
49.66%
0.65
5.12%
capex per share
-0.01
-
-0.05
317.58%
-0.14
196.50%
-0.17
25.88%
-0.11
36.42%
-0.02
78.07%
-0.98
3,920.47%
-0.14
85.38%
-0.02
88.30%
-0.01
15.74%
-0.03
107.68%
capex to depreciation
-0.49
-
-1.00
103.15%
-2.79
178.73%
-2.88
3.32%
-1.37
52.35%
-0.19
85.92%
-3.96
1,949.25%
-0.20
94.98%
-0.29
45.68%
-0.02
91.46%
-0.46
1,771.17%
capex to operating cash flow
0.04
-
0.13
227.25%
-0.04
127.54%
0.25
816.44%
0.13
50.81%
0.04
64.97%
-1.87
4,363.10%
0.22
111.63%
0.02
89.55%
0.06
157.47%
0.07
23.43%
capex to revenue
-0.03
-
-2.58
7,338.90%
-0.41
84.01%
-0.17
59.51%
-0.18
10.41%
-0.02
90.31%
-0.95
5,201.23%
-0.20
79.06%
-0.11
44.68%
-0.02
79.42%
-0.05
100.66%
cash per share
1.07
-
1.38
29.22%
4.42
220.00%
3.67
16.93%
2.14
41.79%
2.85
33.42%
3.27
14.76%
1.92
41.27%
1.51
21.58%
1.27
15.42%
1.15
9.82%
days of inventory on hand
45.27
-
44.99
0.61%
45.26
-
days payables outstanding
247.59
-
206.73
16.50%
225.80
-
3.54K
1,469.67%
days sales outstanding
206.72
-
3.45K
1,571.23%
202.78
94.13%
166.08
18.10%
168.72
1.59%
669.94
297.06%
69.54
89.62%
139.33
100.36%
555.09
298.40%
281.96
49.20%
390.71
38.57%
debt to assets
0.09
-
0.05
46.22%
0.01
73.54%
0.02
54.19%
0.02
21.54%
0.01
56.42%
0.05
365.47%
0.06
33.09%
0.17
166.44%
0.20
22.87%
0.22
6.55%
debt to equity
0.12
-
0.06
52.88%
0.05
7.58%
0.06
18.68%
0.07
10.35%
0.03
60.37%
0.09
218.49%
0.12
42.10%
0.41
236.57%
0.78
89.44%
0.77
1.49%
dividend yield
0.00
-
earnings yield
-0.02
-
-0.05
229.16%
-0.01
81.58%
0.02
275.85%
-0.18
1,249.50%
0.01
103.78%
-0.05
853.52%
-0.26
392.43%
-0.17
35.44%
-0.38
126.29%
-0.04
90.51%
enterprise value
158.43M
-
336.12M
112.16%
585.13M
74.08%
616.45M
5.35%
168.58M
72.65%
289.21M
71.56%
214.61M
25.80%
155.57M
27.51%
294.30M
89.18%
220.04M
25.23%
180.07M
18.16%
enterprise value over ebitda
-71.78
-
-18.83
73.76%
-72.33
284.06%
52.94
173.20%
-4.73
108.93%
23.39
594.65%
-24.16
203.28%
3.61
114.94%
-7.98
321.08%
6.52
181.70%
-10.40
259.51%
ev to operating cash flow
-14.45
-
-18.54
28.31%
2.81
115.18%
-16.73
694.39%
-3.51
79.03%
-8.89
153.45%
6.15
169.12%
-3.00
148.87%
-5.03
67.66%
-11.49
128.19%
-5.53
51.86%
ev to sales
12.71
-
370.59
2,816.71%
32.68
91.18%
10.98
66.41%
5.17
52.93%
3.62
29.93%
3.11
14.05%
2.74
12.03%
24.30
787.68%
4.43
81.76%
3.47
21.73%
free cash flow per share
-0.29
-
-0.41
38.62%
3.75
1,019.66%
-0.86
122.86%
-1.00
15.92%
-0.58
41.94%
-0.46
21.16%
-0.80
75.47%
-0.75
5.96%
-0.25
66.13%
-0.43
70.44%
free cash flow yield
-0.06
-
-0.05
12.97%
0.27
628.39%
-0.06
121.52%
-0.21
251.22%
-0.08
62.34%
-0.08
1.65%
-0.23
202.07%
-0.17
26.80%
-0.08
54.21%
-0.17
114.03%
graham net net
0.81
-
1.20
47.78%
0.18
85.25%
0.40
124.20%
-0.71
277.84%
-0.11
84.46%
0.71
746.24%
0.21
70.67%
-0.33
259.19%
-0.29
11.23%
0.02
107.73%
graham number
1.32
-
3.62
173.76%
1.95
46.08%
2.91
48.82%
5.63
93.67%
1.82
67.62%
4.79
162.64%
6.31
31.89%
4.75
24.70%
4.36
8.21%
1.17
73.22%
income quality
3.79
-
0.92
75.66%
-31.00
3,459.07%
-2.92
90.60%
0.99
134.07%
-10.67
1,174.16%
-1.68
84.23%
0.81
148.13%
1.11
36.71%
0.33
70.22%
4.30
1,204.67%
intangibles to total assets
0
-
0.06
Infinity%
0.03
46.20%
0.03
1.32%
0.18
462.00%
0.19
3.43%
0.24
28.96%
0.15
37.68%
0.17
9.72%
0.01
95.47%
0.00
69.83%
interest coverage
-14.40
-
-121.01
740.50%
-77.50
35.96%
61.06
178.79%
-353.83
679.52%
50.45
114.26%
-132.61
362.85%
-2.02
98.47%
-11.97
491.01%
-2.19
81.70%
-12.21
457.72%
interest debt per share
0.13
-
0.09
32.71%
0.07
16.35%
0.10
38.80%
0.11
8.68%
0.08
28.46%
0.28
259.57%
0.33
15.77%
0.61
85.22%
0.60
1.52%
0.52
13.17%
inventory turnover
8.06
-
8.11
0.61%
8.06
-
invested capital
0.12
-
0.06
52.88%
0.05
7.58%
0.06
18.68%
0.07
10.35%
0.03
60.37%
0.09
218.49%
0.12
42.10%
0.41
236.57%
0.78
89.44%
0.77
1.49%
market cap
191.97M
-
396.20M
106.39%
734.25M
85.32%
787.03M
7.19%
262.09M
66.70%
437.00M
66.74%
398.77M
8.75%
273.27M
31.47%
353.81M
29.47%
262.02M
25.94%
210.79M
19.55%
net current asset value
33.75M
-
63.25M
87.39%
18.24M
71.17%
34.67M
90.11%
-31.55M
190.99%
35.67M
213.06%
53.66M
50.45%
21.88M
59.22%
-21.80M
199.62%
-13.88M
36.33%
15.72M
213.25%
net debt to ebitda
15.20
-
3.37
77.85%
18.43
447.56%
-14.65
179.48%
2.62
117.90%
-11.95
555.74%
20.73
273.44%
-2.73
113.17%
1.61
159.08%
-1.24
177.08%
1.77
242.61%
net income per share
-0.07
-
-0.39
424.27%
-0.13
67.94%
0.23
286.85%
-0.89
479.39%
0.05
105.83%
-0.31
704.04%
-0.90
186.04%
-0.74
17.05%
-1.24
67.38%
-0.09
92.44%
operating cash flow per share
-0.28
-
-0.36
27.60%
3.89
1,176.79%
-0.68
117.57%
-0.88
29.26%
-0.55
37.41%
0.52
194.31%
-0.66
225.74%
-0.73
11.97%
-0.24
67.27%
-0.40
68.26%
payables turnover
1.47
-
1.77
19.76%
1.62
-
0.10
93.63%
receivables turnover
1.77
-
0.11
94.02%
1.80
1,603.71%
2.20
22.10%
2.16
1.57%
0.54
74.81%
5.25
863.37%
2.62
50.09%
0.66
74.90%
1.29
96.87%
0.93
27.83%
research and ddevelopement to revenue
1.67
-
0.87
48.16%
2.05
137.13%
0.87
57.60%
0.02
97.34%
1.03
4,356.97%
3.88
276.29%
1.04
73.18%
1.08
3.71%
return on tangible assets
-0.05
-
-0.23
344.92%
-0.02
90.17%
0.05
304.90%
-0.23
599.50%
0.01
103.59%
-0.07
928.32%
-0.27
293.36%
-0.26
2.25%
-0.48
81.39%
-0.04
91.43%
revenue per share
0.32
-
0.02
94.39%
0.34
1,754.12%
1.04
210.91%
0.60
42.41%
1.36
126.40%
1.03
24.16%
0.72
30.16%
0.15
78.85%
0.62
309.33%
0.65
3.50%
roe
-0.07
-
-0.26
266.74%
-0.09
64.66%
0.15
257.64%
-0.56
483.74%
0.02
103.24%
-0.10
628.92%
-0.45
370.38%
-0.55
21.35%
-1.83
232.50%
-0.15
92.03%
roic
-0.06
-
-0.24
330.46%
-0.14
42.42%
0.08
155.04%
-0.42
648.06%
0.03
107.82%
-0.11
443.68%
-0.08
25.76%
-0.40
374.82%
-0.20
49.74%
-0.11
47.19%
sales general and administrative to revenue
0.83
-
13.79
1,555.29%
0.31
97.74%
0.16
49.36%
0.48
203.45%
0.23
52.67%
0.59
160.07%
0.55
6.90%
1.32
140.14%
0.29
77.92%
shareholders equity per share
1.04
-
1.49
42.95%
1.35
9.30%
1.60
18.53%
1.58
1.13%
2.85
79.92%
3.25
14.20%
1.98
39.19%
1.35
31.64%
0.68
49.66%
0.65
5.12%
stock based compensation to revenue
0.03
-
0.42
1,494.71%
0.06
86.42%
0.02
67.49%
0.30
1,540.77%
0.03
88.75%
0.06
63.71%
0.04
21.49%
0.22
396.15%
0.09
60.38%
tangible asset value
40.29M
-
69.26M
71.93%
62.34M
10.00%
77.09M
23.68%
39.76M
48.42%
82.71M
108.00%
120.45M
45.63%
109.69M
8.94%
63.25M
42.34%
52.59M
16.84%
51.48M
2.11%
tangible book value per share
1.04
-
1.38
32.68%
1.17
15.48%
1.43
22.60%
0.73
48.88%
1.41
92.35%
1.80
27.93%
1.39
22.81%
0.80
42.78%
0.66
16.94%
0.65
2.32%
working capital
40.07M
-
68.54M
71.04%
191.96M
180.08%
153.64M
19.97%
63.61M
58.60%
122.91M
93.21%
115.78M
5.80%
126.64M
9.38%
58.37M
53.91%
98.49M
68.74%
108.38M
10.03%

All numbers in USD (except ratios and percentages)